OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
All-trans retinoic acid (ATRA) inhibits insufficient radiofrequency ablation (IRFA)-induced enrichment of tumor-initiating cells in hepatocellular carcinoma
Song Wang, Jianwen Liu, Hao Wu, et al.
Chinese Journal of Cancer Research (2021) Vol. 33, Iss. 6, pp. 694-707
Open Access | Times Cited: 8
Song Wang, Jianwen Liu, Hao Wu, et al.
Chinese Journal of Cancer Research (2021) Vol. 33, Iss. 6, pp. 694-707
Open Access | Times Cited: 8
Showing 8 citing articles:
Clinical outcomes and tumor microenvironment response to radiofrequency ablation therapy: a systematic review and meta-analysis
Lauren Mueller, Peter P. Issa, Mohammad H. Hussein, et al.
Gland Surgery (2024) Vol. 13, Iss. 1, pp. 4-18
Open Access | Times Cited: 5
Lauren Mueller, Peter P. Issa, Mohammad H. Hussein, et al.
Gland Surgery (2024) Vol. 13, Iss. 1, pp. 4-18
Open Access | Times Cited: 5
Radiofrequency ablation: mechanisms and clinical applications
Jianhua Wu, Zhiyuan Zhou, Yuanwen Huang, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 3
Jianhua Wu, Zhiyuan Zhou, Yuanwen Huang, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 3
Biological roles and clinical applications of EpCAM in HCC
Peng Liu, Qun Zhang, Fengchao Liu
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Peng Liu, Qun Zhang, Fengchao Liu
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
All-Trans Retinoic Acid Promotes M2 Macrophage Polarization in Vitro by Activating the p38MAPK/STAT6 Signaling Pathway
Ya-nan Zhu, Xiao-li Gu, Lin-yuan Wang, et al.
Immunological Investigations (2023) Vol. 52, Iss. 3, pp. 298-318
Closed Access | Times Cited: 7
Ya-nan Zhu, Xiao-li Gu, Lin-yuan Wang, et al.
Immunological Investigations (2023) Vol. 52, Iss. 3, pp. 298-318
Closed Access | Times Cited: 7
Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma
Bowen Hu, Jie Gao, Jihua Shi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Bowen Hu, Jie Gao, Jihua Shi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Efficacy and safety of anlotinib as an adjuvant therapy in hepatocellular carcinoma patients with a high risk of postoperative recurrence
Jianguo Wang, Xiaonan Xiang, Zhixiong Shi, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 4, pp. 399-407
Open Access | Times Cited: 3
Jianguo Wang, Xiaonan Xiang, Zhixiong Shi, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 4, pp. 399-407
Open Access | Times Cited: 3
Prognostic prediction signature and molecular subtype for liver cancer: A CTC/CTM‑related gene prediction model and independent external validation
Ling Xu, Qiansheng Wu, Kai Zhao, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access
Ling Xu, Qiansheng Wu, Kai Zhao, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access
Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation
Feilong Ye, Lulu Xie, Licong Liang, et al.
Journal of interventional medicine (2023) Vol. 6, Iss. 4, pp. 160-169
Open Access | Times Cited: 1
Feilong Ye, Lulu Xie, Licong Liang, et al.
Journal of interventional medicine (2023) Vol. 6, Iss. 4, pp. 160-169
Open Access | Times Cited: 1
